(1)
Chu, D.; Stephenson, B.; Lee, J.; Bannister, B.; Hickey, C.; Westley, T.; Zirwas, M. Clinical Efficacy and Patient Reported Impacts of Roflumilast Foam 0.3% in Seborrheic Dermatitis: An Analysis of STRATUM Data for Patients Unresponsive or Intolerant to Topical Corticosteroids. J of Skin 2024, 8, s397.